Pcn76 - Budget Impact Analysis of Afatinib for the First-Line Treatment of Advanced or Metastatic Non–small-Cell Lung Cancer in China
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.158
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV